By Jessica Baladad, Breast Cancer Survivor and Patient Advocate The pronouncement of "no evidence of disease" is...
Patient Advocacy and Support
San Francisco, CA – February 3, 2026 – For Cynthia Lohr, a seasoned partner of the National...
WASHINGTON, D.C. — As the heat of summer begins to wane, the national advocacy landscape is bracing...
Breast Cancer Awareness Month (BCAM), observed annually in October, serves as a crucial period for collective action,...
TORONTO, ON – In the landscape of Canadian oncology, the paradigm of treatment is shifting from a...
Breast cancer is no longer viewed as a single, monolithic disease but as a complex spectrum of...
By Madison Decker, NBCF Charitable Advancement Manager, with contributions from Katie Mooneyham, Strategic Partnerships Coordinator, and Candace...
The landscape of oncology is currently witnessing a transformative shift as the U.S. Food and Drug Administration...
By [Your Name/Organization Name], Reporting The news that a loved one will not recover from an illness...
The Dawn of De-Escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
The Dawn of De-Escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
The landscape of oncology is currently undergoing a quiet but profound revolution. For decades, the mantra of...
